Stay updated on Docetaxel + Plinabulin Clinical Trial
Sign up to get notified when there's something new on the Docetaxel + Plinabulin Clinical Trial page.

Latest updates to the Docetaxel + Plinabulin Clinical Trial page
- Check3 days agoChange DetectedThe study record now displays details of the completed Phase 3 trial of docetaxel plus plinabulin versus docetaxel plus placebo for advanced NSCLC, including its design, eligibility, locations, outcomes, and study documents.SummaryDifference89%

- Check10 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check17 days agoChange DetectedA sitewide banner announces NIH updates and says the agency is transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check24 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.SummaryDifference0.2%

- Check31 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check52 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the expected content, indicating the record is currently inaccessible. The added 403 header and related text reflect a temporary access issue rather than a content update.SummaryDifference20%

Stay in the know with updates to Docetaxel + Plinabulin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Docetaxel + Plinabulin Clinical Trial page.